Clinical Research Directory
Browse clinical research sites, groups, and studies.
Predicting Efficacy of Preoperative Immunotherapy in Advanced Gastric Cancer
Sponsor: Ruijin Hospital
Summary
This study intends to employ FAPI and Grazytracer PET/CT to predict the therapeutic response to preoperative immunotherapy-based combination regimens in patients with advanced gastric cancer. The study is expected to provide an early, non-invasive predictive tool for immunotherapy-based combination therapy in gastric cancer, offer molecular imaging-based evidence for treatment stratification, and facilitate the optimization of precision therapeutic strategies.
Official title: Predicting Efficacy of Preoperative Immunotherapy Combined Treatment in Advanced Gastric Cancer
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
120
Start Date
2025-06-17
Completion Date
2033-05-31
Last Updated
2026-09-17
Healthy Volunteers
No
Conditions
Interventions
FAPI PET/CT Imaging
A FAP-targeted radiotracer for PET/CT imaging; administered intravenously.
Grazytracer PET/CT Imaging
A Granzyme B-targeted radiotracer for PET/CT imaging; administered intravenously.
Locations (1)
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China